풍진 진단 검사 시장 규모, 점유율, 성장 분석 : 검사 방법별, 용도별, 검사 유형별, 지역별 - 업계 예측(2026-2033년)

Global Rubella Diagnostic Testing Market size was valued at USD 1.35 Billion in 2024 and is poised to grow from USD 1.42 Billion in 2025 to USD 2.23 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The global rubella diagnostic testing market is witnessing significant growth driven by the increasing emphasis on preventing congenital rubella syndrome and validating vaccinations as part of disease elimination strategies. Manufacturers and laboratories are advancing immunoassays and PCR technologies to enhance detection of rubella infection and immunity. The rising adoption of serology screening, particularly in regions like Brazil and India, has fostered the development of multiplex assays that screen for both measles and rubella. This evolution from sporadic outbreak testing to comprehensive surveillance is further supported by regulatory momentum and the integration of multiplex technologies, enabling cost-effective detection and quicker outbreak response. Additionally, the expansion of laboratory networks presents new opportunities, encouraging innovation in rapid diagnostic formats suitable for point-of-care applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Rubella Diagnostic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Rubella Diagnostic Testing Market Segments Analysis

Global rubella diagnostic testing market is segmented by testing technique, application, test type and region. Based on testing technique, the market is segmented into latex agglutination, enzyme immunoassay, radioimmunoassay and fluorescent immunoassay. Based on application, the market is segmented into hospitals, laboratories and other applications. Based on test type, the market is segmented into IgM antibody testing, IgG antibody testing and molecular testing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Rubella Diagnostic Testing Market

The global demand for rubella diagnostic testing is significantly driven by the rising integration of rubella vaccination into routine immunization programs across various regions. As health authorities prioritize the evaluation of immune status and the detection of breakthrough infections, the need for reliable diagnostic tools has become essential. These diagnostics enable healthcare providers to assess the success of vaccination initiatives, shape public health strategies, and safeguard vulnerable populations. The emphasis on achieving comprehensive immunization coverage in both public and private healthcare sectors is further propelling the demand for these testing kits. Additionally, these assays play a critical role in ongoing surveillance, ensuring regulatory compliance and enhancing readiness for potential outbreaks, thus fueling market expansion.

Restraints in the Global Rubella Diagnostic Testing Market

The Global Rubella Diagnostic Testing market faces significant challenges primarily due to the high costs associated with advanced diagnostic kits. The use of specialized reagents and rigorous quality control measures inflates prices, making it difficult for healthcare facilities in resource-limited settings to access these tools. Public health programs in lower-income areas often prioritize essential services like vaccination over diagnostic testing, constraining their budgets and resulting in a preference for cost-effective solutions. This financial pressure impedes the adoption of higher-quality testing options, leading to reliance on less sensitive methods or delayed diagnosis, ultimately hindering overall market expansion and preventing manufacturers from achieving economies of scale that could lower prices.

Market Trends of the Global Rubella Diagnostic Testing Market

The Global Rubella Diagnostic Testing market is witnessing a significant trend towards immunization-driven surveillance, fueled by the expansion of national immunization programs. Health authorities are enhancing rubella surveillance networks, leading to more frequent and comprehensive diagnostic testing. As rubella screening becomes a routine part of prenatal and pediatric care, the demand for rapid, high-throughput assays is on the rise, facilitating early detection and outbreak containment. This shift not only aligns with global elimination goals but also motivates manufacturers to innovate diagnostic kits for large-scale public health initiatives and engage in strategic collaborations with governmental vaccination agencies to ensure effective regulatory compliance.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Rubella Diagnostic Testing Market Size by Testing Technique & CAGR (2026-2033)

• Market Overview
• Latex Agglutination
• Enzyme Immunoassay
• Radioimmunoassay
• Fluorescent Immunoassay

Global Rubella Diagnostic Testing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Hospitals
• Laboratories
• Other Applications

Global Rubella Diagnostic Testing Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• IgM Antibody Testing
• IgG Antibody Testing
• Molecular Testing

Global Rubella Diagnostic Testing Market Size & CAGR (2026-2033)

• North America (Testing Technique, Application, Test Type)
  • US
  • Canada
• Europe (Testing Technique, Application, Test Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Testing Technique, Application, Test Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Testing Technique, Application, Test Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Testing Technique, Application, Test Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Tandem Diabetes Care Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glaukos Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Silk Road Medical Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biohit Oyj
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIA LAB Services Srl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynex Technologies Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujirebio Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inova Diagnostics Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tosoh Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin SpA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vircell SL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations